TNSN08266A1 - Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit - Google Patents

Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit

Info

Publication number
TNSN08266A1
TNSN08266A1 TNP2008000266A TNSN08266A TNSN08266A1 TN SN08266 A1 TNSN08266 A1 TN SN08266A1 TN P2008000266 A TNP2008000266 A TN P2008000266A TN SN08266 A TNSN08266 A TN SN08266A TN SN08266 A1 TNSN08266 A1 TN SN08266A1
Authority
TN
Tunisia
Prior art keywords
reverse transcriptase
nucleotide
tenofovir
lamivudine
nucleoside reverse
Prior art date
Application number
TNP2008000266A
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2006/004687 external-priority patent/WO2007068934A2/en
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of TNSN08266A1 publication Critical patent/TNSN08266A1/en

Links

Abstract

A pharmaceutical formulation for the treatment of HIV is provided. The formulation is a combination of a nucleoside reverse transcriptase inhibitor and a nucleotide reverse transcriptase inhibitor in which the combination has an increased stability over prior, art combination therapies. The invention also provides a pharmaceutical product containing the formulation.
TNP2008000266A 2005-12-14 2008-06-16 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit TNSN08266A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1566MU2005 2005-12-14
PCT/GB2006/004687 WO2007068934A2 (en) 2005-12-14 2006-12-14 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit

Publications (1)

Publication Number Publication Date
TNSN08266A1 true TNSN08266A1 (en) 2009-10-30

Family

ID=41022655

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000266A TNSN08266A1 (en) 2005-12-14 2008-06-16 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit

Country Status (3)

Country Link
ES (1) ES2349479T3 (en)
TN (1) TNSN08266A1 (en)
ZA (1) ZA200805254B (en)

Also Published As

Publication number Publication date
ZA200805254B (en) 2009-04-29
ES2349479T3 (en) 2011-01-04

Similar Documents

Publication Publication Date Title
WO2007068934A3 (en) Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit
NO20071077L (en) Phosphonate analogues for HIV inhibitor compounds
ATE493413T1 (en) ANHYDROUS CRYSTALLINE FORMS OF N-Ä1,2- ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINOÜ-7-(4- METHYLPYRIDINE-2-YL-AMINOÜ-1H-PYRAZOLOÄ4,3-
IL181987A0 (en) Diaminotriazole derivatives and pharmaceutical compositions containing the same
NO20081592L (en) Dipeptidyl peptidase inhibitors for the treatment of diabetes
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
MXPA05008368A (en) Hiv inhibiting 1,2,4-triazines.
ATE430747T1 (en) 2-PYRIMIDINYL-PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS
IS7817A (en) Phenylalanine derivatives which dipeptidyl peptidase inhibit the treatment or prevention of diabetes.
UA100005C2 (en) Inhibitors of human immunodeficiency virus replication
GEP20125691B (en) Compounds and compositions as protein kinase inhibitors
EP2526934A3 (en) Inhibitors of bruton's tyrosine kinase
NO20070866L (en) Antiviral compounds.
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
WO2008028965A3 (en) Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof
GB0226434D0 (en) Combination product
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
HK1112228A1 (en) Substituted azachinzolines having an antiviral action
TN2009000119A1 (en) Combination drug
WO2007113243A3 (en) Use of pde 5 inhibitors for the treatment of overactive bladder
MY140530A (en) Antineoplasic compounds and pharmaceuticals compositions thereof
IL191670A0 (en) Compounds for the inhibition of apoptosis
IL198630A0 (en) Pyrimidyl derivatives as protein kinase inhibitors
TNSN08266A1 (en) Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit